Emory University, Atlanta, GA

Home Page
About SAEN
Articles and Reports
Contact Us
Events and Campaigns
Fact Sheets
Financial Information
How You Can Help
Make a Donation, Please!
Media Coverage
Picture Archive
Press Releases
Resources and Links
Grass Roots Org. List

Stop Animal Exploitation NOW!
S. A. E. N.
"Exposing the truth to wipe out animal experimentation"

Government Grants Promoting Cruelty to Animals

Emory University, Atlanta, GA

LEONARD L. HOWELL - Primate Testing - 2006

Grant Number: 2K02DA000517-06
Project Title: Neuropharmacology of Cocaine in Nonhuman Primates
HOWELL, leonard@rmy.emory.edu 

Abstract: DESCRIPTION (provided by applicant):
The career development plan described in this competing renewal application will allow the applicant to continue the development and expansion of his research career into new areas of investigation that complement current areas of expertise. The applicant has extensive training and experience in behavioral neuropharmacology and substance abuse with primary expertise in the neuropharmacology of CMS stimulants. During the previous funding period, the applicant developed in vivo microdialysis techniques in conscious monkeys trained to self-administer cocaine and related stimulants in order to determine neurochemical changes associated with the behavioral and reinforcing properties of abused stimulants. In addition, the development of positron emission tomography (PET) imaging techniques in conscious monkeys expanded further the applicant's ability to characterize and quantify the CMS effects of abused stimulants. More recent efforts have focused on the development of functional magnetic resonance imaging (fMRI) in conscious monkeys to document with high temporal and spatial resolution drug-induced changes in CMS activity. A major focus of the research plan will involve the pharmacological manipulation of monoamine and glutamate systems to assess potential changes in sensitivity to the CNS effects of cocaine. The studies proposed will provide an innovative preclinical model to identify useful pharmacotherapies for stimulant abuse. In addition to research activities, the applicant will commit effort to educational activities related to biomedical research and substance abuse. The host institution, Emory University, has a well-established program related to neuroscience and substance abuse research that is ideally suited to the career development plan. The University will provide the necessary resources and adequate time to ensure the development of the applicant as a productive, independent research scientist. The long-term commitment and support provided by continuation of the Independent Scientist Award will provide the opportunity to develop and integrate new skills and expertise into a unique multidisciplinary research program in substance abuse.

Thesaurus Terms:
cocaine, neurochemistry, neuropharmacology amine, brain imaging /visualization /scanning, central nervous system stimulant, dopamine, injection /infusion, microdialysis, neuropsychology, operant conditioning, psychological reinforcement, reinforcer, self medication, serotonin, substance abuse related behavior, technology /technique development Macaca mulatta, Saimiri, behavior test, drug abuse chemotherapy, positron emission tomography, stereotaxic technique

Fiscal Year: 2006
Project Start: 01-MAR-2001
Project End: 31-MAR-2011

Neuropsychopharmacology (2006) 31, 585593. doi:10.1038/sj.npp.1300828; published online 27 July 2005

Preclinical Research
Olanzapine-Induced Suppression of Cocaine Self-Administration in Rhesus Monkeys

Leonard L Howell1,2, Kristin M Wilcox1, Kimberly P Lindsey1 and Heather L Kimmel1

Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA 2Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA


General Methods

Six female and four male adult rhesus monkeys (Macaca mulatta) weighing 7.513.0 kg were used as subjects. Each subject was housed individually and fed Purina monkey chow, fruits, and vegetables. Water was continuously available. Animal care procedures strictly followed the NIH 'Guide for the Care and Use of Laboratory Animals' and were approved by the Institutional Animal Care and Use Committee of Emory University.


Each subject was prepared with a chronic indwelling venous catheter under sterile surgical conditions using a technique described previously (Wilcox et al, 2002). Preoperative antibiotics (Rocephin, 25 mg/kg or Cefazolin, 25 mg/kg) were given on the day of surgery to help prevent infection. A silicone catheter (0.65 mm ID, 1.75 mm OD; Access Technologies, Skokie, IL) was implanted under a combination of Telazol (4.0 mg/kg) and isoflurane anesthesia using aseptic techniques. The proximal end of the catheter terminated in the vena cava above the right atrium, and the distal end was routed under the skin and attached to a subcutaneous vascular access port (Access Technologies, Skokie, IL) located in the center of the lower back. After surgery, the subject was returned to its home cage and received Banamine (1.0 mg/kg) every 6 h for 24 h postoperatively to reduce pain and discomfort associated with surgery. Catheters were flushed daily with 100 U/ml heparinized saline to maintain patency. In experiments involving in vivo microdialysis, guide cannulae were implanted bilaterally into the caudate nucleus under sterile conditions. The positioning of the guide cannulae allowed for targeting of the ventral striatum corresponding to the nucleus accumbens. Preoperative antibiotics (Rocephin, 25 mg/kg) were given on the day of surgery to help prevent infection. The animals were sedated with Telazol (4.0 mg/kg) and maintained on isoflurane anesthesia during the surgery. The subjects were positioned in a stereotaxic frame, and coordinates derived from MRI were used for accurate probe placement. A trephine drill was used to make two small burr holes directly above the ventral striatum, and the guide cannulae were inserted to the appropriate depth. Teflon screws attached to the skull were used to anchor cranioplastic cement, and the guide cannulae were enclosed within a small plastic chamber to prevent access by the monkeys. Stainless-steel stylets were placed in the guide cannulae when not in use. Monkeys were allowed to recover from surgery for 2 weeks before initiating microdialysis experiments. All animals received Banamine (1.0 mg/kg) every 6 for 24 h postoperatively, or longer if they exhibited signs of discomfort.

Cocaine HCl (National Institute on Drug Abuse, Rockville, MD) and fluoxetine HCl (Eli Lilly and Company) were dissolved in 0.9% saline. Drug doses were determined as salts. Olanzapine (Eli Lilly and Company) was dissolved in 0.01 N HCl and diluted with distilled water to appropriate concentrations.
During behavioral testing, each monkey was seated in a commercially available primate chair (Primate Products, Redwood City, CA, USA), and a response panel with one lever was mounted on the front of chair. Located above the lever in the center of the response panel were red and white stimulus lights. Once the monkey was seated in the chair, a Huber needle (Access Technologies, Skokie, IL) was inserted into the venous access port. The polyvinyl-chloride tubing attached to the Huber needle was connected to a motor-driven syringe (Coulbourn Instruments, Allentown, PA) located outside of the chamber containing the drug solution. A volume of 2.0 ml/infusion was delivered over 7 s. Testing during daily 1-h sessions occurred in a ventilated, sound-attenuating chamber. IBM compatible computers controlled experimental events and recorded data.
Subjects responded for i.v. infusions of cocaine under a second-order schedule of reinforcement, as described previously (Wilcox et al, 2002). The training dose of cocaine was 0.1 mg/kg/infusion. When the daily session began, the red light on the response panel was illuminated and responding resulted in the delivery of a drug infusion and brief 2-s illumination of the white light. Initially, the fixed ratio (FR) was one (FR 1) and gradually increased to FR 20. Ultimately, a second-order schedule of reinforcement was in effect, with the first FR 20 completed after 10 min (fixed-interval, FI 10) resulting in a drug infusion. FR 20 components completed within the 10-min FI resulted in illumination of the white light for 2 s. There was a 30-s limited hold for completion of the first FR 20 after the FI 10 had elapsed, and a drug infusion was not delivered if the limited hold expired. Drug infusions were signaled by a change in the lights from red to white for 15 s. Following each drug infusion there was a 1-min timeout during which responding on the lever had no programmed consequences. A total of five infusions could be delivered during a daily session comprising five FI 10-min (FR 20:s) components.

The training sequence remained in effect until responding for cocaine was stable (<20% variance in daily response rate over five consecutive days), after which saline was substituted for cocaine until responding decreased to below 30% of responding for the training dose of cocaine. After saline extinction, the maintenance dose (0.1 mg/kg/infusion) of cocaine was reinstated and responding was allowed to stabilize. For pretreatment studies, a given dose of drug was administered i.v. 15 min presession on three consecutive days, typically Tuesday, Wednesday, and Thursday. Vehicle was administered on all days that subjects did not receive a drug pretreatment, and these data contributed to ongoing calculations of baseline stability. Pretreatment doses were administered on two separate occasions in an ascending order. All doses of a particular drug were studied in combination with 0.1 mg/kg/infusion cocaine first. Subsequently, the maintenance dose of cocaine was changed to 0.3 mg/kg/infusion, and drug pretreatments were repeated as described above. For drug-substitution studies, each subject was allowed to self-administer several doses of olanzapine in a randomized order. Substitution for each drug dose continued for at least five consecutive sessions, or until responding stabilized (<20% variance in daily response rate).

Please email:  LEONARD L. HOWELL, leonard@rmy.emory.edu  to protest the inhumane use of animals in this experiment. We would also love to know about your efforts with this cause: saen@saenonline.org

Return to Grants
Return to Emory University, Atlanta, GA
Return to Facility Reports and Information
Return to Resources and Links

Rats, mice, birds, amphibians and other animals have been excluded from coverage by the Animal Welfare Act. Therefore research facility reports do not include these animals. As a result of this situation, a blank report, or one with few animals listed, does not mean that a facility has not performed experiments on non-reportable animals. A blank form does mean that the facility in question has not used covered animals (primates, dogs, cats, rabbits, guinea pigs, hamsters, pigs, sheep, goats, etc.). Rats and mice alone are believed to comprise over 90% of the animals used in experimentation. Therefore the majority of animals used at research facilities are not even counted.

We welcome your comments and questions

This site is hosted and maintained by:
The Mary T. and Frank L. Hoffman Family Foundation
Thank you for visiting all-creatures.org.
Since date.gif (991 bytes)